Lv6
2460 积分 2023-08-21 加入
Pharmacokinetics and pharmacodynamics of inclisiran, a small interfering RNA therapy, in patients with hepatic impairment
16小时前
待确认
Proprotein convertase subtilisin/kexin Type 9 inhibitors: past, present, and future
14天前
已完结
LDL Cholesterol Lowering With Evolocumab Before Percutaneous Coronary Intervention for Acute Myocardial Infarction The AMUNDSEN Randomized Clinical Trial
1个月前
已完结
Lepodisiran - A Long-Duration Small Interfering RNA Targeting Lipoprotein(a)
3个月前
已完结
Improving stroke risk prediction in atrial fibrillation with circulating biomarkers: the CHA2DS2-VASc–Biomarkers model
3个月前
已关闭
Lipoprotein(a) and family history for cardiovascular disease in paediatric patients: A new frontier in cardiovascular risk stratification. Data from the LIPIGEN paediatric group
4个月前
已完结
ESOC 2023 Abstract Book
4个月前
已完结
Association of Lipoprotein(a) and Interleukin-6 With Cardiovascular Risk: MESA and UK Biobank
4个月前
已完结
Pharmacokinetics and pharmacodynamics of inclisiran, a small interfering RNA therapy, in patients with hepatic impairment
5个月前
已完结
皖公网安备34019202002308
